Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 943-950

  Yeo, Anthony E T ^a   Seymour, Kristen K ^a   Rieckmann, Karl H ^b   Christopherson, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

antifolates; atovaquone; dapsone; malaria; synergism

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; ATOVAQUONE; CYCLOGUANIL; DAPSONE; FOLIC ACID ANTAGONIST; N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE; PROGUANIL; PYRIMETHAMINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG DNA BINDING; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0030969974     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00835-0     Document Type: Article

References (35)

1. Armstrong VL and Smith CC, Cyclization and N-dealkylation of chlorguanide by rabbit and rat hepatic microsomes. Toxicol Appl Pharmacol 29: 90, 1974.
2. Ferone R, Burchall JJ and Hitchings GH, Plasmodium berghei dihydrofolate reductase. Isolation, properties and inhibition by antifolates. Mol Pharmacol 5: 49-59, 1969.
3. Ferone R, Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei. J Biol Chem 245: 850-854, 1970.
4. McCulloch JL and Maren TH, Dihydropteroate synthase from Plasmodium berghei: Isolation, properties and inhibition by dapsone and sulfadiazine. Mol Pharmacol 10: 140-145, 1974.
5. Canfield CJ, Milhous WK, Ager AL, Rossan RN, Sweeney TR, Lewis NJ and Jacobus DP, PS-15: A potent orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg 49: 121-126, 1993.
6. Rieckmann KH, The in vitro activity of experimental antimalarial compounds against strains of Plasmodium falciparum with varying degrees of sensitivity to pyrimethamine and chloroquine. Chemotherapy of malaria and resistance to antimalarials. World Health Organ Tech Rep Ser 529: 58, 1973.
7. Canfield CJ, New antimalarials under development. In: Chemotherapy of Malaria (Ed. Bruce-Chwatt LK), 2nd Edn, pp. 99-100. WHO Monograph Series, No. 27, 1986.
8. Childs GE and Lambros C, Analogues of N-benzyloxy-hydrotriazines: In vitro antimalarial activity against Plasmodium falciparum. Ann Trop Med Parasitol 80: 177-181, 1986.
9. Walter RD, Folate metabolism as a target for chemotherapy of malaria. In: Biochemical Protozoology (Eds. Coombs GH and North MJ), pp. 560-568. Taylor & Francis, London, 1991.
10. Canfield CJ, Pudney M and Gutteridge WE, Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80: 373-381, 1995.
11. Blanchard TJ, Mabey DCW, Hunt-Cooke A, Edwards G, Hutchinson DBA, Benjamin S and Chiodini PL, Multiresistant falciparum malaria cured using atovaquone and proguanil. Trans R Soc Trop Med Hyg 88: 693, 1994.
12. Fry M and Pudney M, Site of action of the antimalarial hydroxynapththoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol 43: 1545-1553, 1992.
13. Gutteridge WE, Dave D and Richards WHG, Conversion of dihydroorotate to orotate in parasitic protozoa. Biochim Biophys Acta 582: 97-109, 1979.
14. Hammond DJ, Burchell JR and Pudney M, Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol 14: 97-109, 1985.
15. Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, Ballou WR, Foulds G, Sadoff JC, Schuster B and Taylor DN, Azithromycin prophylaxis against a chloroquine resistant strains of Plasmodium falciparum. Lancet 343: 1396-1397, 1994.
16. Lyons SD and Christopherson RI, Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in L1210 leukemia. Biochem Int 22: 939-949, 1990.
17. Yeo AET and Rieckmann KH, Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases antimalarial activity. J Parasitol 80: 158-160, 1994.
18. Berenbaum MC, A method for testing synergy with any number of agents. J Infect Dis 137: 122-130, 1978.
19. Berenbaum MC, Correlations between methods for measurement of synergy. J Infect Dis 142: 476-478, 1980.
20. Thaithong S and Beale GH, Resistance often Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Trans R Soc Trop Med Hyg 75: 271-273, 1981.
21. Trager W and Jensen JB, Human malaria parasites in continuous culture. Science 193: 673-675, 1976.
22. Lambros C and Vanderberg JP, Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420, 1979.
23. Yeo AET and Rieckmann KH, A bioassay for mefloquine. J Parasitol 78: 1096-1097, 1992.
24. Seymour KK, Lyons SD, Phillips L, Rieckmann KH and Christopherson RI, Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry 33: 5268-5274, 1994.
25. Sherman PA and Fyfe JA, Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal Biochem 180: 222-226, 1989.
26. Watkins WM, Brandling-Bennett AD, Nevill CG, Carter JY, Boriga DA, Howells RE and Koech DK, Chlorproguanil/ dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: A pilot study. Trans R Soc Trop Med 82: 398-403, 1988.
27. Winstanley PA, Mberu EK, Szwandt ISF, Breckenridge AM and Watkins WM, The in vitro activity of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte colony forming units. Antimicrob Agents Chemother 39: 948-952, 1995.
28. Fry M and Beesley JE, Mitochondria of mammalian Plasmodia species. Parasitology 102: 17-26, 1991.
29. Yeo AET and Rieckmann KH, The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum. Trans R Soc Trop Med Hyg 86: 234, 1992.
30. Araujo FG, Guptill DR and Remington JS, Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother 32: 755-757, 1988.
31. Gingras BA and Jensen JB, Activity of azithromycin (CP-62,993) and erythromycin against chloroquine sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg 47: 378-382, 1992.
32. Gingras BA and Jensen JB, Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. Am J Trop Med Hyg 49: 101-105, 1993.
33. Hooper DC and Wolfson JS, Mode of action of the quinolone antimicrobial agents. Rev Infect Dis 10 (Suppl 1): S514-S521, 1988.
34. Forsgren A, Bredberg A, Pardee AB, Schlossman SF and Tedder TF, Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 31: 774-779, 1987.
35. 10-enzymes, succinoxidase and NADH-oxidase by adriamycin and other quinones having antitumor activity. Biochem Biophys Res Commun 58: 633-638, 1974.